Wolverine Asset Management LLC Boosts Stock Holdings in Aimei Health Technology Co., Ltd (NASDAQ:AFJK)

Wolverine Asset Management LLC raised its holdings in Aimei Health Technology Co., Ltd (NASDAQ:AFJK) by 21.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 654,039 shares of the company’s stock after purchasing an additional 115,000 shares during the period. Wolverine Asset Management LLC owned 7.24% of Aimei Health Technology worth $6,998,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of AFJK. Mizuho Securities USA LLC increased its stake in shares of Aimei Health Technology by 60.7% in the third quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company’s stock worth $4,627,000 after purchasing an additional 167,223 shares in the last quarter. Glazer Capital LLC increased its stake in shares of Aimei Health Technology by 3.4% in the third quarter. Glazer Capital LLC now owns 608,670 shares of the company’s stock worth $6,379,000 after purchasing an additional 19,896 shares in the last quarter. Rivernorth Capital Management LLC increased its stake in shares of Aimei Health Technology by 9.1% in the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock worth $1,811,000 after purchasing an additional 14,391 shares in the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of Aimei Health Technology in the third quarter worth about $123,000. Hedge funds and other institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Stock Performance

AFJK opened at $10.90 on Friday. The firm has a 50-day moving average price of $10.75 and a 200-day moving average price of $10.59. Aimei Health Technology Co., Ltd has a twelve month low of $10.15 and a twelve month high of $11.00.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.